Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $57,143 - $72,218
-241 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$257.27 - $315.76 $21,610 - $26,523
-84 Reduced 25.85%
241 $70,000
Q2 2021

Jul 23, 2021

BUY
$225.08 - $271.69 $2,250 - $2,716
10 Added 3.17%
325 $87,000
Q4 2019

Jan 17, 2020

SELL
$133.47 - $153.48 $6,006 - $6,906
-45 Reduced 12.5%
315 $48,000
Q3 2019

Oct 11, 2019

BUY
$135.4 - $146.47 $1,760 - $1,904
13 Added 3.75%
360 $52,000
Q2 2019

Jul 18, 2019

SELL
$124.88 - $143.73 $35,965 - $41,394
-288 Reduced 45.35%
347 $50,000
Q1 2019

Apr 17, 2019

BUY
$97.62 - $132.29 $25,478 - $34,527
261 Added 69.79%
635 $84,000
Q3 2017

Oct 12, 2017

BUY
$79.29 - $88.45 $29,654 - $33,080
374
374 $32,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.